Xeris Biopharma Inc.
(XERS)
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 67.45M | 121.97M | 121.97M | 67.27M | 37.60M | 45.72M | 42.05M | 32.27M |
Short-Term Investments | 5.00M | - | 35.16M | 35.16M | 96.19M | 66.92M | - | - |
Long-Term Investments | - | 4.35M | -364.00K | - | 13.23M | - | - | - |
Other Long-Term Assets | 4.54M | 267.00K | 4.73M | 829.00K | -13.00M | 95.00K | 157.00K | 47.00K |
Receivables | 39.20M | 30.83M | 17.46M | 6.88M | 4.69M | 2.87M | 1.20M | 101.00K |
Inventory | 38.84M | 24.73M | 24.73M | 18.12M | 8.35M | - | 1.00 | - |
Other Current Assets | 5.78M | 9.29M | 4.59M | 3.20M | 5.07M | 2.40M | 809.00K | 804.00K |
Total Current Assets | 156.26M | 186.82M | 186.82M | 142.60M | 152.21M | 117.90M | 44.05M | 33.17M |
Property-Plant & Equipment | 29.18M | 28.38M | 28.38M | 6.63M | 6.71M | 2.03M | 788.00K | 312.00K |
Goodwill & Intangibles | 132.62M | 124.60M | 124.60M | 154.31M | - | - | - | - |
Total Long-Term Assets | 166.34M | 157.70M | 157.70M | 161.76M | 6.94M | 2.13M | 945.00K | 359.00K |
Total Assets | 322.60M | 344.52M | 344.52M | 304.36M | 159.15M | 120.03M | 45.00M | 33.53M |
Account Payables | 11.56M | 4.61M | 8.92M | 3.12M | 5.60M | 866.00K | 1.98M | 1.31M |
Deferred Revenue | - | 64.78M | - | - | - | 232.00K | 234.00K | 263.00K |
Short-Term Debt | 6.99M | 3.16M | - | - | - | - | - | - |
Other Current Liabilities | 76.64M | 65.86M | 70.12M | 25.09M | 21.73M | 9.31M | 2.88M | 1.21M |
Total Current Liabilities | 95.19M | 73.62M | 73.62M | 79.04M | 28.21M | 10.17M | 4.86M | 2.53M |
Long-Term Debt | 225.70M | 196.48M | 88.07M | 87.02M | 58.30M | 31.89M | - | - |
Other Long-Term Liabilities | 6.23M | 25.72M | 37.08M | 10.16M | 8.91M | 2.56M | 97.97M | 62.94M |
Total Long-Term Liabilities | 234.19M | 225.71M | 225.71M | 130.09M | 97.18M | 34.45M | 97.97M | 62.94M |
Total Liabilities | 329.38M | 299.33M | 299.33M | 209.13M | 125.39M | 44.62M | 102.83M | 65.47M |
Total Debt | 229.19M | 198.06M | 198.06M | 88.07M | 87.02M | 31.89M | - | - |
Common Stock | 14.00K | 14.00K | 14.00K | 13.00K | 6.00K | 2.00K | 1K | 1K |
Retained Earnings | -617.02M | -554.77M | -554.77M | -460.11M | -337.38M | -120.67M | -60.59M | -34.03M |
Comprehensive Income | -25.00K | -23.00K | -23.00K | -31.00K | 6.00K | -52.00K | -440.00K | -268.00K |
Shareholders Equity | -6.78M | 45.19M | 45.19M | 95.23M | 33.76M | 75.41M | -57.83M | -31.93M |
Total Investments | 5.00M | 4.35M | 35.16M | 35.16M | 96.19M | 66.92M | - | - |